Skip to content
Screener

D&A at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$520M-25.9%
Haemonetics logo
HaemoneticsHAE
$27.11M-5.7%
Utah Medical Products logo
Utah Medical ProductsUTMD
$211K+5.5%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$30.5M+4.1%
ICU Medical logo
ICU MedicalICUI
$49.61M-0.1%
Boston Scientific logo
Boston ScientificBSX
$351M+8.0%

Segments

By segment

See full
Americas$25.69M+26.1%
EMEA$14.29M+48.6%
Asia$5.52M+150%
Corporate$4.32M-7.8%

Other financials

Income statement

See full
Revenue$570.3M+28.9%
Gross profit$331.7M+24.8%
Operating income$72.8M-20.1%
Net income$99.7M-18.7%
EPS (diluted)$2.28-17.7%

Balance sheet

See full
Cash & equivalents$316.9M+23.5%
Total debt$3.0B+49.5%
Total equity$2.9B-31.5%
Total assets$6.8B-8.0%

Cash flow

See full
Operating cash flow$91.9M+348%
CapEx$14.0M-49.5%
Free cash flow$77.9M+220%

Valuation

See full
Market cap$6.15B+24.1%
Enterprise value$8.81B+31.7%
P/S2.7×-0.1×

Profitability

See full
Gross margin46.7%-4.5pp
Operating margin2%-14.9pp
Net margin-45.8%-56.9pp
FCF margin7.9%

Returns & leverage

See full
Return on equity-28.9%-33.2pp
Debt / equity+0.6×
Current ratio2.6×+0.2×

Where this comes from

Reported directly by Teleflex in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The source filing: Teleflex’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 3:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000096943-26-000095
Line itemSix Months Ended / June 30, 2026Six Months Ended / June 29, 2025
Net income$91,539$217,582
Adjustments to reconcile net income to net cash provided by operating activities:
(Income) loss from discontinued operations(54,615)(97,074)
Depreciation expense35,62024,840
Intangible asset amortization expense67,94350,668
Deferred financing costs and debt discount amortization expense2,9761,705
Loss on extinguishment of debt1,150
Changes in contingent consideration(2,699)14,080

Item 1. Financial Statements (Unaudited):

FAQ

What is Teleflex's D&A?
Teleflex (TFX) reported D&A of $15.77M in Q2 2026.
How has Teleflex's D&A changed year-over-year?
Teleflex's D&A increased by 33.6% year-over-year, from $11.8M to $15.77M.
What is the long-term trend for Teleflex's D&A?
Over 4 years (2021 to 2025), Teleflex's D&A has grown at a -4.9% compound annual growth rate (CAGR), from $71.76M to $58.74M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Ask your AI about Teleflex's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude